Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.34 |
| ▸ | PNMT | P11086 | 4/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.33 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | TEAD1 | P28347 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31345993 | 0.83 | KIF11 (0.33) | PNMTCASP3CASP7CASP8AADAT | |
| SCHEMBL31346026 | 0.82 | PNMT (0.33) | PNMTAADATHRH3PTGS1PTGS2 | |
| SCHEMBL31345984 | 0.80 | PNMT (0.35) | PNMTAADATHRH3PTGS1PTGS2 | |
| SCHEMBL31346002 | 0.76 | TEAD1 (0.42) | HTR2CHTR2BTEAD1 | |
| SCHEMBL31345963 | 0.76 | TEAD1 (0.42) | HTR2CHTR2BTEAD1 | |
| SCHEMBL31346056 | 0.75 | TEAD1 (0.34) | PNMTCASP3CASP7CASP8TEAD1 | |
| SCHEMBL31346022 | 0.75 | FFAR1 (0.39) | PNMTTEAD1 | |
| SCHEMBL31346136 | 0.74 | CYP11B1 (0.40) | PNMTAADATTEAD1 | |
| SCHEMBL31346060 | 0.74 | TERT (0.34) | PNMTHRH3TEAD1 | |
| SCHEMBL31346038 | 0.74 | TERT (0.34) | PNMTHRH3TEAD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |